NASDAQ: IMDX
Insight Molecular Diagnostics Inc.
$4.74
▲ +0.03 (+0.64%)as of 2026-07-17
1-year price · 252 sessions
Key stats
52-week range$4.74
$2.40$8.48
Today
- Open
- 4.75
- Day high
- 4.82
- Day low
- 4.68
- Prev close
- 4.71
- Volume
- 39K
Valuation
- Mkt cap
- $153M
- P/E (TTM)
- —
- EPS (TTM)
- —
- P/B
- -14.3
- P/S
- 78.5
Dividend
- Yield
- —
- Per share
- —
Insider & institutional activity · SEC Form 4 / 13F
- ▲Insiders net buying $2.0M over the last 3 months (4 open-market buys, 0 sales)
- 🏛Institutions accumulating (13F)
Insight Molecular Diagnostics Inc. (IMDX) is a Healthcare company listed on NASDAQ. The stock is up 66% over the past year. Over the trailing 3 months, insiders filed 4 open-market buys and 0 sales (SEC Form 4).
Insight Molecular Diagnostics Inc. (IMDX) financials & analyst ratings
Fundamentals (TTM)
Margins
Gross margin19.5%
Operating margin-2112.4%
Net margin-2454.6%
FCF margin-1408.7%
Growth & returns
Revenue growth-49.3%
Revenue growth (fwd)+251.4%
EPS growth+57.1%
Return on equity447.5%
Return on assets-118.3%
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
IMDX earnings date, history & EPS estimates
Next earnings
Aug 10, 2026in NaN days
EPS est $-0.24 · Revenue est $437500
Track record
Beat EPS in 7 of 12 quarters
Avg surprise +56.6% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 13, 2026 | $-0.26 | $-0.28 | -7.1% | $32000 | -86.0% |
| Mar 26, 2026 | $-0.24 | $-0.27 | -13.7% | $1M | +299.6% |
| Mar 24, 2025 | $-0.43 | $0.48 | +211.6% | $1M | +837.2% |
| Aug 8, 2024 | $-0.56 | $-0.36 | +35.7% | $104000 | -67.5% |
| May 15, 2024 | $-0.67 | $-1.13 | -68.7% | $176000 | -49.7% |
| Mar 29, 2024 | $-1.57 | $-1.94 | -23.3% | $314000 | — |
| Nov 9, 2023 | $-1.52 | $-0.57 | +62.5% | $429000 | +34.1% |
| Aug 10, 2023 | $-2.60 | $-1.07 | +58.8% | $463000 | +28.6% |
| May 11, 2023 | $-2.40 | $-0.80 | +66.7% | $297000 | -15.1% |
| Nov 10, 2022 | $-2.60 | $-1.60 | +38.5% | $1M | -31.5% |
| Aug 10, 2022 | $-2.60 | $-1.40 | +46.2% | $2M | -23.6% |
| Mar 10, 2022 | $-2.00 | $-2.00 | +0.0% | $4M | +1.8% |
IMDX insider trading activity (SEC Form 4)
Sentiment
100/100
Buys (3m)
4
Sells (3m)
0
Net (3m)
$2.0M
Insiders buying
Insider trades by month Buys Sells
Oct
Dec
Jan
Feb
Feb
Apr
Context3-month price +18.8%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 6, 2026 | SILVERMAN LOUdirector | Tax | 7,700 | $5.69 |
| Jul 6, 2026 | Last Andrew J.director | Tax | 7,700 | $5.69 |
| Jul 6, 2026 | Arno Andrewdirector | Tax | 12,100 | $5.69 |
| Jun 15, 2026 | Arno Andrewdirector | Grant | 32,331 | — |
| Jun 15, 2026 | Last Andrew J.director | Grant | 26,943 | — |
| Jun 15, 2026 | SILVERMAN LOUdirector | Grant | 26,943 | — |
| Apr 27, 2026 | BROADWOOD PARTNERS, L.P.10 percent owner | Buy | 280,381 | $3.50 |
| Apr 27, 2026 | BROADWOOD PARTNERS, L.P.10 percent owner | Buy | 250,923 | $3.64 |
| Apr 27, 2026 | BROADWOOD PARTNERS, L.P.10 percent owner | Buy | 38,880 | $3.53 |
| Apr 27, 2026 | BROADWOOD PARTNERS, L.P.10 percent owner | Buy | 0 | — |
| Apr 20, 2026 | BROADWOOD PARTNERS, L.P.10 percent owner | Buy | 0 | — |
| Apr 20, 2026 | BROADWOOD PARTNERS, L.P.10 percent owner | Buy | 102,057 | $3.45 |
| Apr 20, 2026 | BROADWOOD PARTNERS, L.P.10 percent owner | Buy | 40,690 | $3.88 |
| Apr 20, 2026 | BROADWOOD PARTNERS, L.P.10 percent owner | Buy | 40,114 | $3.57 |
| Mar 30, 2026 | James Andrea S.officer: Chief Financial Officer | Tax | 11,298 | $4.11 |
Source: IMDX SEC Form 4 filings, latest Jul 6, 2026. For informational purposes only — not investment advice.
See the full IMDX insider & 13F page →Track IMDX with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free